PodParley PodParley
PodParley
MOUNTAINEER Study in discussion w/ Dr. Bekaii-Saab (Tucatinib and Trastuzumab FDA Approval for advanced colorectal cancer) episode artwork

EPISODE · Feb 27, 2023 · 17 MIN

MOUNTAINEER Study in discussion w/ Dr. Bekaii-Saab (Tucatinib and Trastuzumab FDA Approval for advanced colorectal cancer)

from Oncology Brothers: Practice-Changing Cancer Discussions · host Oncology Brothers

Discussing the MOUNTAINEER Phase II study, which resulted in the FDA approval of the Tucatinib and Trastuzumab combination for advanced colorectal cancer HER2 positive patients. In discussion with the lead author, Dr. Tanios S. Bekaii-Saab - Medical Oncology Chief, Leader of Enterprise Wide GI Cancer Program at Mayo Clinic Comprehensive Cancer Center. Website: http://www.oncbrothers.com/ Twitter: https://twitter.com/oncbrothers Contact us at [email protected]

Episode metadata supplied by the publisher feed · Published Feb 27, 2023

Embed this episode

NOW PLAYING

MOUNTAINEER Study in discussion w/ Dr. Bekaii-Saab (Tucatinib and Trastuzumab FDA Approval for advanced colorectal cancer)

0:00 17:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Brothers: Practice-Changing Cancer Discussions?

This episode is 17 minutes long.

When was this Oncology Brothers: Practice-Changing Cancer Discussions episode published?

This episode was published on February 27, 2023.

Can I download this Oncology Brothers: Practice-Changing Cancer Discussions episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!